These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10557042)

  • 21. [Relation between TEL-AML1 expression level and clinical characteristics as well as early response to treatment in children with acute lymphoblastic leukemia].
    Li ZG; Zhao W; Gao Z; Wu MY; Zhang YH; Shi HW; Xie J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):523-7. PubMed ID: 17605858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction.
    Seeger K; Kreuzer KA; Lass U; Taube T; Buchwald D; Eckert C; Körner G; Schmidt CA; Henze G
    Cancer Res; 2001 Mar; 61(6):2517-22. PubMed ID: 11289124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TEL/AML1 positivity in childhood ALL: average or better prognosis? Czech Paediatric Haematology Working Group.
    Zuna J; Hrusák O; Kalinová M; Muzíková K; Starý J; Trka J
    Leukemia; 1999 Jan; 13(1):22-4. PubMed ID: 10049055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TEL/AML1 fusion gene in childhood acute lymphoblastic leukemia in southern Taiwan.
    Lin PC; Chang TT; Lin SR; Chiou SS; Jang RC; Sheen JM
    Kaohsiung J Med Sci; 2008 Jun; 24(6):289-96. PubMed ID: 18635414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic significance of the TEL-AML1 fusion gene in pediatric acute lymphoblastic leukemia in Turkey.
    Ozbek U; Sirma S; Agaoglu L; Yuksel L; Anak S; Yildiz I; Devecioglu O; Timur C; Meral A; Gedikoglu G
    J Pediatr Hematol Oncol; 2003 Mar; 25(3):204-8. PubMed ID: 12621238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TEL/AML-1 fusion gene. its frequency and prognostic significance in childhood acute lymphoblastic leukemia.
    Jamil A; Theil KS; Kahwash S; Ruymann FB; Klopfenstein KJ
    Cancer Genet Cytogenet; 2000 Oct; 122(2):73-8. PubMed ID: 11106814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia.
    Drunat S; Olivi M; Brunie G; Grandchamp B; Vilmer E; Bièche I; Cavé H
    Br J Haematol; 2001 Aug; 114(2):281-9. PubMed ID: 11529845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia.
    Nakao M; Yokota S; Horiike S; Taniwaki M; Kashima K; Sonoda Y; Koizumi S; Takaue Y; Matsushita T; Fujimoto T; Misawa S
    Leukemia; 1996 Sep; 10(9):1463-70. PubMed ID: 8751464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.
    McHale CM; Wiemels JL; Zhang L; Ma X; Buffler PA; Guo W; Loh ML; Smith MT
    Genes Chromosomes Cancer; 2003 May; 37(1):36-43. PubMed ID: 12661004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.
    de Haas V; Oosten L; Dee R; Verhagen OJ; Kroes W; van den Berg H; van der Schoot CE
    Br J Haematol; 2000 Dec; 111(4):1080-6. PubMed ID: 11167743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity. The Pediatric Hematology Working Group in the Czech Republic.
    Hrusák O; Trka J; Zuna J; Housková J; Bartůnková J; Starý J
    Leukemia; 1998 Jul; 12(7):1064-70. PubMed ID: 9665191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
    Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
    Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
    Pine SR; Wiemels JL; Jayabose S; Sandoval C
    Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Holleman A; Appel IM; Beverloo HB; van Wering ER; Janka-Schaub GE; Evans WE; Pieters R
    Blood; 2005 Jun; 105(11):4223-5. PubMed ID: 15718422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.